Temporal interference stimulation in Parkinson's disease: STN vs GPi targets
Official title: Comparative Efficacy of Temporal Interference Stimulation at Different Targets in Parkinson's Disease
Run by Zhongnan Hospital · NCT07745673 · Data updated 2026-11-12
This study tests whether stimulating the subthalamic nucleus or the globus pallidus internus with temporal interference stimulation improves motor symptoms in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 18 (estimated) |
| Sponsor | Zhongnan Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Status | Recruiting |
| Started | June 29, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 4, 2026 |
| Trial ID | NCT07745673 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with idiopathic Parkinson's disease, H&Y 1.5–2.5, good dopaminergic response, capable of consent and daily visits for 7 days.
✕Probably not a fit
Individuals with cognitive impairment (MoCA ≤23), severe gait issues, or unstable medications may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, participant- and outcome-assessor-blinded, parallel-group trial in adults with Parkinson's disease. Participants are randomized 1:1 to receive either STN-targeted or GPi-targeted temporal interference stimulation (TIS) for 20 minutes daily over 7 days. Motor function is measured with MDS-UPDRS Part III before and after each session, and resting-state fMRI and 64-channel EEG are recorded before the first session and after the final session to explore neural changes. Primary outcome is the change in MDS-UPDRS Part III from Day 1 before stimulation to Day 7, with secondary imaging and electrophysiological endpoints.
Why it matters
Potential benefit: If successful, this approach could offer a non-invasive option to improve motor symptoms in Parkinson's disease by targeting different brain regions.
How similar studies have gone: Previous non-invasive neuromodulation strategies have shown variable motor benefits in Parkinson's, and this targeted, blinded comparison is among first to compare STN vs GPi with TIS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult males or females aged ≥40 years; 2. Diagnosis of idiopathic Parkinson's disease according to the UK Brain Bank criteria, with age of onset ≥40 years; 3. Previous or current treatment with dopamine replacement therapy (e.g., levodopa) with good response; 4. Hoehn and Yahr (H\&Y) stage 1.5-2.5; 5. Able to walk independently for at least 5 minutes without assistive devices; 6. No severe freezing of gait (FOG); 7. Disease duration ≥2 years since diagnosis, clinically stable, and able to comply with study assessments and interventions; 8. Stable medication regimen for at least 4 weeks prior to the study; 9. Signed informed consent form; subject or legal guardian is able to understand and willing to participate in this study. Exclusion Criteria: 1. Presence of other neurological disorders that may affect the study (e.g., ...); 2. Mild cognitive impairment or above (MoCA ≤23); 3. Orthopedic or other medical conditions that may affect gait or balance; 4. Contraindications to MRI, such as claustrophobia; 5. History of antipsychotic, antidepressant, or other medications that may affect dopamine levels; 6. History of other severe psychiatric disorders; 7. History of epilepsy, traumatic brain injury, or implanted metallic devices in the brain or heart (e.g., stimulators, pacemakers) or other contraindications; 8. History of electroconvulsive therapy (ECT); 9. Currently participating in other gait- or balance-related intervention training; 10. Physician-diagnosed cardiovascular risk factors for exercise.
Where it's running
-
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China Recruiting
Study contacts
- Study coordinator: Yang Pan
- Email: panyang.zn@whu.edu.cn
- Phone: 13952098253
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mobile app-guided gait training for Parkinson's disease
A mobile app will test whether audio cues plus gentle vibrations can help people with Parkinson's walk more easily and stay balanced during a 6-week gait program.
-
CAIX-targeted PET/CT imaging in solid tumors
Researchers are testing a CAIX-targeted PET/CT imaging agent to see if it detects and reflects CAIX levels in solid tumors like clear cell renal cell carcinoma, NSCLC, and breast cancer.
-
Pigmentary glaucoma: does a 120° ab-interno trabeculotomy help
This study will see if performing an ab-interno 120° trabeculotomy can lower eye pressure and reduce medication needs in people with pigmentary glaucoma over six months.
-
Bowel Sounds and Day-to-Day Recovery After Colorectal Cancer Surgery
This study will test whether monitoring bowel sounds before and after colorectal cancer surgery can predict how quickly patients recover bowel function and resume eating.
-
Multi-omics analysis linking zonular laxity and primary angle‑closure glaucoma
It will test whether molecular differences in eye fluid, blood, and the anterior lens capsule link zonular laxity to primary angle‑closure glaucoma in adults aged 50 and older.
-
How three reading methods affect medical students' understanding of English medical papers
This project tests whether reading original English, using a bilingual comparison, or relying on a full translation helps medical students understand English medical papers more accurately, reduces mental effort, and improves academic writing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.